Pharmanovia

Sustainability Report and Carbon Intensity Rankings

Is Pharmanovia doing their part?

Their DitchCarbon score is 64

Pharmanovia has a DitchCarbon Score of 64, indicating a moderate level of sustainability in their operations. This score reflects the company’s efforts to manage and reduce its carbon intensity. A higher score would signify even greater success in minimizing their environmental impact through lower carbon emissions.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Pharmanovia is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Pharmanovia, located in the United Kingdom, operates in a region with a very low carbon intensity rating. This suggests that the company’s sustainability efforts are positively influenced by the country’s commitment to low carbon emissions.

Unlock 30+ emissions data points on Pharmanovia

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Pharmanovia

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

22.71%

...this company is doing 22.71% better in emissions than the industry average.

Pharmanovia is a specialty pharmaceutical company based in the GB Industrial Manufacturing Sector, founded in 2003. The company specializes in the commercialization and marketing of niche pharmaceutical products and medical devices, primarily in the Nordics and Europe. Pharmanovia’s core activities include acquiring mature branded medicines, in-licensing, developing niche generics, and portfolio balancing through divestment.

emission intelligence's platform recommendations for Pharmanovia

Pharmanovia should consider fuel switching in their transportation and operations to capitalize on the potential 15% emissions reduction.

Good news, Pharmanovia has set solid SBTi commitments

Pharmanovia has committed to Science Based Targets initiative (SBTi) by setting targets to significantly reduce their greenhouse gas emissions from company operations, which include direct emissions and indirect emissions from purchased energy. Their commitment aligns with the ambitious goal of limiting global temperature rise to 1.5°C, reflecting a strong dedication to environmental sustainability.
Participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Looking for a specific company?

Search our company directory or contact us for custom data requests.